The drug has the potential to address an unmet need
The companies have started a global pivotal Phase II/III safety and efficacy study
The move secures AZ access to the Japanese drug giant’s experimental antibody drug conjugate
Updated Date: Mon, 20 Jul 2020 00:00:00 EDT
Updated Date: Mon, 20 Jul 2020 00:00:00 EDT
Updated Date: Mon, 20 Jul 2020 00:00:00 EDT
Updated Date: Mon, 20 Jul 2020 00:00:00 EDT
Updated Date: Mon, 20 Jul 2020 00:00:00 EDT
Europe’s COVID-19 vaccine negotiations hit snags with 3 drugmakers: Reuters esagonowsky Mon, 07/27/2020 – 14:58
